Intel revealed the findings from a new study conducted in partnership with Convergys Analytics that surveyed 200 U.S. healthcare decision-makers on their attitudes about artificial intelligence (AI) and perceived barriers to adoption in the industry.
The study found that among the respondents whose organizations use AI, clinical use (77 percent) currently outpaces operational (41 percent) and financial use (26 percent). Additionally, the benefits of AI are widely recognized, with 91 percent of respondents believing it will provide predictive analytics for early intervention, 88 percent saying the technology will improve care, and 83 percent saying it will improve accuracy of medical diagnoses.
However, trust remains the biggest obstacle to implementing AI in healthcare. More than one-third of those surveyed say patients won’t trust AI to play an active role in their healthcare, and 30 percent assumed that clinicians won’t trust it either - they fear fatal error is the largest barrier to adoption.
To realize the true potential of AI in healthcare, it is imperative that the technology industry work with partners in healthcare to start building trust now by addressing the “black box“ perception of AI, leaning into areas where clinicians are ready for change and fatal error is less likely, highlighting benefits for all involved and providing input into the regulatory process.
“At the end of the day, we are all consumers of healthcare, and we should feel confident that advances in technology can ensure we receive high-quality, affordable care,“ said Jennifer Esposito, worldwide general manager of Health and Life Sciences at Intel. “Together, we can ensure patients and providers realize the benefits of AI in healthcare today, building trust and understanding that will help us unlock incredible advances in the future.“
The GSMA has issued a warning that escalating smartphone component costs, fueled by the massive demand for AI infrastructure, risk widening the global digital divide and making mobile internet increasingly unaffordable in low- and middle-income countries (LMICs).
Global semiconductor revenue reached a new record of $425 billion in the second quarter of 2026, marking an unprecedented 31.4% quarter-over-quarter (QoQ) growth rate, according to Omdia.
The convergence of massive AI infrastructure investment and the deep embedding of AI into software services is driving global spending to unprecedented levels, according to Gartner.
